§ 54.1-3442.1

Definitions

As used in this article, unless the context requires a different meaning:”Investigational drug, biological product, or device” means a drug, biological product, or device that has successfully completed Phase I of a clinical trial but has not been approved for general use by the U.S. Food and Drug Administration and remains under investigation in a clinical trial.”Terminal condition” means a condition caused by injury, disease, or illness from which, to a reasonable degree of medical probability, a patient cannot recover and (i) the patient’s death is imminent or (ii) the patient is in a persistent vegetative state.”Treating physician” means a physician who is providing or has previously provided medical treatment or evaluation to and has or previously had an ongoing treatment relationship with the person.

History

2015, cc. 655, 656.

Download

  • Plain Text
  • JSON
  • XML